CLSDQ · Clearside Biomedical, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current plans and forecasted expenses and our cash and cash equivalents, we do not believe we will be able to fund our operations for the next 12 months from the date of this filing. These factors raise substantial doubt regarding our ability to continue as a going concern.”